Literature DB >> 11599326

Raloxifene and breast cancer.

J Lorraine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11599326      PMCID： PMC81493     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Raloxifene: handle with care.

Authors:  K I Pritchard; M Levine; B Walley
Journal:  CMAJ       Date:  2001-07-24       Impact factor: 8.262

2.  Uterine effects of 3-year raloxifene therapy in postmenopausal women younger than age 60.

Authors:  F J Cohen; S Watts; A Shah; R Akers; L Plouffe
Journal:  Obstet Gynecol       Date:  2000-01       Impact factor: 7.661

3.  Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation.

Authors:  J A Cauley; L Norton; M E Lippman; S Eckert; K A Krueger; D W Purdie; J Farrerons; A Karasik; D Mellstrom; K W Ng; J J Stepan; T J Powles; M Morrow; A Costa; S L Silfen; E L Walls; H Schmitt; D B Muchmore; V C Jordan; L G Ste-Marie
Journal:  Breast Cancer Res Treat       Date:  2001-01       Impact factor: 4.872

4.  Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.

Authors:  D Grady; N K Wenger; D Herrington; S Khan; C Furberg; D Hunninghake; E Vittinghoff; S Hulley
Journal:  Ann Intern Med       Date:  2000-05-02       Impact factor: 25.391

5.  Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen.

Authors:  L Bergman; M L Beelen; M P Gallee; H Hollema; J Benraadt; F E van Leeuwen
Journal:  Lancet       Date:  2000-09-09       Impact factor: 79.321

6.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

Authors:  B Fisher; J P Costantino; D L Wickerham; C K Redmond; M Kavanah; W M Cronin; V Vogel; A Robidoux; N Dimitrov; J Atkins; M Daly; S Wieand; E Tan-Chiu; L Ford; N Wolmark
Journal:  J Natl Cancer Inst       Date:  1998-09-16       Impact factor: 13.506
  6 in total
  1 in total

Review 1.  Tamoxifen for breast cancer prevention: safety warning.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2002-08-20       Impact factor: 8.262
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.